SCHEMBL4572772

SCHEMBL4572772

Brc1c([Si](c2ccccc2)(c2ccccc2)c2ccccc2)cc(-c2ccccc2)cc1[Si](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
ALDH1A1 P00352 4/20 0.39
MAPK1 P28482 3/20 0.39
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
NOTUM Q6P988 1/20 0.34
AKR1C4 P17516 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
MCL1 Q07820 1/20 0.33
NLRP3 Q96P20 1/20 0.33
HDAC8 Q9BY41 1/20 0.32
CYP19A1 P11511 1/20 0.32
EGFR P00533 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28752013 0.80 ALDH1A1 (0.41) CRHBPCRHR2ALDH1A1MAPK1NPC1
SCHEMBL4572727 0.79 ALDH1A1 (0.38) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL4572739 0.77 CRHBP (0.43) CRHBPCRHR2ALDH1A1MAPK1NPC1
SCHEMBL28595147 0.75 TDP1 (0.32)
SCHEMBL16115917 0.73 NPC1 (0.41) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL13681168 0.73 ALDH1A1 (0.43) CRHBPCRHR2ALDH1A1MAPK1NPC1
SCHEMBL4572736 0.73 ALDH1A1 (0.45) CRHBPCRHR2ALDH1A1MAPK1NPC1
SCHEMBL26310616 0.73 ALDH1A1 (0.45) CRHBPCRHR2ALDH1A1MAPK1NPC1
SCHEMBL28864155 0.72 ALDH1A1 (0.43) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL24050315 0.71 ALDH1A1 (0.43) CRHBPCRHR2ALDH1A1MAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080303019-A1 Side Chain-Containing Type Organic Silane Compound, Thin Film Transistor and Method of Producing Thereof SHARP KABUSHIKI KAISHA (JP) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080303019-A1 Side Chain-Containing Type Organic Silane Compound, Thin Film Transistor and Method of Producing Thereof CBX3, SOS1, AOX1 CRHBP 4466/4885CRHR2 3209/4885ALDH1A1 425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.